Literature DB >> 12893430

Topical inhibition of oral carcinoma cell with polymer delivered celecoxib.

Zhi Wang1, Raju Polavaram, Stanley M Shapshay.   

Abstract

Celecoxib has a potential role for oral cancer chemoprevention but its systemic side effects are a concern. Topical chemoprevention is a promising way to reduce the toxicity. This study was designed to determine whether topical application of polymer delivered celecoxib would have an inhibitory effect on human oral carcinoma cells. Seventeen nude mice were intradermally inoculated with the carcinoma cells, and then were divided into control and treatment groups. Tumor growth was measured for 15 days, at which significant difference was found between two groups (P<0.001). This study indicates a potential role of polymer film delivered celecoxib for topical inhibition of oral cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12893430     DOI: 10.1016/s0304-3835(03)00272-6

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  4 in total

1.  In vitro characterization of chitosan gels for buccal delivery of celecoxib: influence of a penetration enhancer.

Authors:  Yara Peluso Cid; Vinícius Pedrazzi; Valéria Pereira de Sousa; Maria Bernadete Riemma Pierre
Journal:  AAPS PharmSciTech       Date:  2011-12-09       Impact factor: 3.246

2.  Chemopreventive effect of celecoxib in oral precancers and cancers.

Authors:  Lining Feng; Zhi Wang
Journal:  Laryngoscope       Date:  2006-10       Impact factor: 3.325

3.  Topical chemoprevention of skin cancer in mice, using combined inhibitors of 5-lipoxygenase and cyclo-oxygenase-2.

Authors:  L Fegn; Zhi Wang
Journal:  J Laryngol Otol       Date:  2009-02-16       Impact factor: 1.469

4.  Characterization of the rheological, mucoadhesive, and drug release properties of highly structured gel platforms for intravaginal drug delivery.

Authors:  Gavin P Andrews; Louise Donnelly; David S Jones; Rhonda M Curran; Ryan J Morrow; A David Woolfson; R Karl Malcolm
Journal:  Biomacromolecules       Date:  2009-09-14       Impact factor: 6.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.